tiprankstipranks
Advertisement
Advertisement

PLRX Stock Latest News

Pliant Therapeutics adds independent directors to strengthen R&D
Company AnnouncementsPliant Therapeutics adds independent directors to strengthen R&D
10d ago
8K
PLRX
Pliant Therapeutics Shareholders Approve Directors and Executive Pay
PremiumCompany Announcements
Pliant Therapeutics Shareholders Approve Directors and Executive Pay
1M ago
8K
PLRX
Analyst Reiterates Hold on Pliant Therapeutics, Keeps 12-Month Price Target Unchanged at $3 Amid Early-Stage Risk-Reward Balance
PremiumRatings
Analyst Reiterates Hold on Pliant Therapeutics, Keeps 12-Month Price Target Unchanged at $3 Amid Early-Stage Risk-Reward Balance
2M ago
PLRX
Pliant Therapeutics reports Q1 EPS (32c), consensus (36c)
PremiumThe Fly
Pliant Therapeutics reports Q1 EPS (32c), consensus (36c)
2M ago
PLRX
PLRX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
PLRX Earnings this Week: How Will it Perform?
3M ago
PLRX
Pliant Therapeutics doses first participant in FORTIFY expansion trial
PremiumThe FlyPliant Therapeutics doses first participant in FORTIFY expansion trial
3M ago
PLRX
Pliant announces presentation of updated data from Phase 1 trial of PLN-101095
Premium
The Fly
Pliant announces presentation of updated data from Phase 1 trial of PLN-101095
3M ago
PLRX
Pliant Therapeutics Announces Board Retirements and Option Repricing
Premium
Company Announcements
Pliant Therapeutics Announces Board Retirements and Option Repricing
3M ago
8K
PLRX
Pliant Therapeutics Launches New $50 Million ATM Program
PremiumCompany Announcements
Pliant Therapeutics Launches New $50 Million ATM Program
4M ago
8K
PLRX
Pliant Therapeutics files $300M mixed securities shelf
PremiumThe Fly
Pliant Therapeutics files $300M mixed securities shelf
4M ago
PLRX
Pliant Therapeutics price target lowered to $3 from $4 at Canaccord
PremiumThe Fly
Pliant Therapeutics price target lowered to $3 from $4 at Canaccord
4M ago
PLRX
How Shareholder Activism Could Disrupt Pliant Therapeutics’ Strategy, Costs, and Stock Performance
PremiumCompany Announcements
How Shareholder Activism Could Disrupt Pliant Therapeutics’ Strategy, Costs, and Stock Performance
4M ago
PLRX
Pliant Therapeutics price target lowered to $3 from $4 at Piper Sandler
PremiumThe FlyPliant Therapeutics price target lowered to $3 from $4 at Piper Sandler
4M ago
PLRX
Pliant Therapeutics reports Q4 EPS (38c), consensus (38c)
Premium
The Fly
Pliant Therapeutics reports Q4 EPS (38c), consensus (38c)
4M ago
PLRX
Pliant Therapeutics Extends Stockholder Rights Agreement Expiration
Premium
Company Announcements
Pliant Therapeutics Extends Stockholder Rights Agreement Expiration
5M ago
8K
PLRX
PLRX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
PLRX Earnings this Week: How Will it Perform?
5M ago
PLRX
Pliant Therapeutics Appoints Minnie Kuo as COO
PremiumCompany Announcements
Pliant Therapeutics Appoints Minnie Kuo as COO
7M ago
8K
PLRX
Pliant Therapeutics Announces Departure of Chief Medical Officer
PremiumCompany Announcements
Pliant Therapeutics Announces Departure of Chief Medical Officer
8M ago
8K
PLRX
Pliant Therapeutics announces interim data from PLN-101095
PremiumThe Fly
Pliant Therapeutics announces interim data from PLN-101095
8M ago
PLRX
Pliant Therapeutics Reports Improved Q3 2025 Results
PremiumCompany AnnouncementsPliant Therapeutics Reports Improved Q3 2025 Results
9M ago
PLRX
Pliant Therapeutics reports Q3 EPS (43c), consensus (52c)
Premium
The Fly
Pliant Therapeutics reports Q3 EPS (43c), consensus (52c)
9M ago
PLRX
Pliant Therapeutics Announces CBO Hans Hull’s Resignation
Premium
Company Announcements
Pliant Therapeutics Announces CBO Hans Hull’s Resignation
9M ago
8K
PLRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >